We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+5.58%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$1B
AUM Growth
+$81M
Cap. Flow
+$45.6M
Cap. Flow %
4.55%
Top 10 Hldgs %
62.52%
Holding
4,698
New
814
Increased
789
Reduced
1,481
Closed
1,566

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$13.3M
2
MSFT icon
Microsoft
MSFT
+$11.7M
3
XOM icon
ExxonMobil
XOM
+$10.9M
4
BAC icon
Bank of America
BAC
+$8.84M
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$8.82M

Sector Composition

Rank Sector Weight
1 Financials 1.7%
2 Technology 1.64%
3 Materials 1.4%
4 Healthcare 1.37%
5 Industrials 1.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IGPT icon
2201
Invesco AI and Next Gen Software ETF
IGPT
$1.2B
$5K ﹤0.01%
+300
New +$5K
IVR icon
2202
Invesco Mortgage Capital
IVR
$807M
$5K ﹤0.01%
30
-106
-78% -$16K
JBLU icon
2203
JetBlue
JBLU
$2.14B
$5K ﹤0.01%
265
-400
-60% -$8.16K
JWN
2204
DELISTED
Nordstrom
JWN
$5K ﹤0.01%
100
-4,780
-98% -$213K
KF
2205
Korea Fund
KF
$267M
$5K ﹤0.01%
+130
New +$4.5K
KIM icon
2206
Kimco Realty
KIM
$16.4B
$5K ﹤0.01%
266
-30,069
-99% -$723K
HAPN
2207
Happen Inc
HAPN
$2.27B
$5K ﹤0.01%
191
-1,200
-86% -$34.1K
LITE icon
2208
Lumentum
LITE
$81.2B
$5K ﹤0.01%
100
-1,750
-95% -$77.2K
MCHI icon
2209
iShares MSCI China ETF
MCHI
$6.16B
$5K ﹤0.01%
98
-56
-36% -$2.7K
MKSI icon
2210
MKS Inc
MKSI
$20.6B
$5K ﹤0.01%
+78
New +$5.13K
NBIX icon
2211
Neurocrine Biosciences
NBIX
$15.4B
$5K ﹤0.01%
107
+55
+106% +$2.36K
OTEX icon
2212
Open Text
OTEX
$5.92B
$5K ﹤0.01%
100
-6,784
-99% -$226K
PAVM icon
2213
PAVmed
PAVM
$32.3M
$5K ﹤0.01%
2
PCRX icon
2214
Pacira BioSciences
PCRX
$925M
$5K ﹤0.01%
119
-109
-48% -$4.71K
PGEN icon
2215
Precigen
PGEN
$2.28B
$5K ﹤0.01%
243
-9,912
-98% -$221K
PI icon
2216
Impinj
PI
$5.28B
$5K ﹤0.01%
155
-544
-78% -$17.1K
PLG
2217
Platinum Group Metals
PLG
$191M
$5K ﹤0.01%
230
-531
-70% -$9.24K
PXI icon
2218
Invesco Dorsey Wright Energy Momentum ETF
PXI
$55.6M
$5K ﹤0.01%
117
+96
+457% +$3.98K
RHI icon
2219
Robert Half
RHI
$4.43B
$5K ﹤0.01%
100
-1,294
-93% -$62.5K
RLGT icon
2220
Radiant Logistics
RLGT
$408M
$5K ﹤0.01%
1,037
+481
+87% +$2.21K
HIND
2221
Vyome Holdings
HIND
$14.9M
0
SLM icon
2222
SLM Corp
SLM
$5.23B
$5K ﹤0.01%
381
-19,493
-98% -$231K
SLQD icon
2223
iShares 0-5 Year Investment Grade Corporate Bond ETF
SLQD
$2.38B
$5K ﹤0.01%
+100
New +$5.03K
SPWH icon
2224
Sportsman's Warehouse
SPWH
$46.8M
$5K ﹤0.01%
1,088
+886
+439% +$5.51K
TG icon
2225
Tredegar Corp
TG
$276M
$5K ﹤0.01%
260
-20
-7% -$417

Similar funds

Tower Research Capital (TRC)'s Q1 2017 Portfolio in Review

As of Q1 2017, Tower Research Capital (TRC) held 4,698 positions worth $1B, up 8.8% from $921M the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Tower Research Capital (TRC) deployed $45.6M of net new capital in Q1 2017, opening 814 new positions and adding to 789 existing holdings. Its largest new stake was ProShares Ultra Russell2000: 717,004 shares worth $20.7M.

By sector, the portfolio is most concentrated in Financials at 1.7% of assets, down from 14% a quarter earlier, followed by Technology and Materials.

On the sell side, the largest reduction was Apple, an estimated $13.3M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2017 buy was ProShares Ultra Russell2000: 717,004 shares worth $20.7M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q1 2017, an estimated $213M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2017 reduction was Apple, cutting an estimated $13.3M.
  • Tower Research Capital (TRC) fully exited Berkshire Hathaway Class B in Q1 2017, selling an estimated $8.82M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 63% of its $1B portfolio in Q1 2017.
  • Tower Research Capital (TRC) opened 814 new positions and closed 1,566 in Q1 2017.
  • Tower Research Capital (TRC)'s portfolio value rose 8.8% quarter-over-quarter to $1B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2017, filed 19 May 2017.